Improved Detection of Virus-Specific IgM Antibodies.
Elimination of Non-Specific IgM Binding (Accepted 22 February 1978) SUMMARY A non-specific reaction between human IgM and cytoplasmic structures of virus infected cells can often be observed if IgM antibodies to virus antigens are detected by indirect immunofluorescence or by immuno enzyme assays. Formaldehyde selectively inactivates the cytoplasmic receptors for human IgM without affecting the virus structural proteins. Alternatively, receptor-free antigens can be obtained by isolation of nuclei from virus infected cells. Due to reduced background, a more specific and more sensitive detection of IgM antibodies to EpsteinBarr virus, cytomegalovirus or central European encephalitis virus is possible.
Detection of specific IgM antibodies is of great value for the diagnosis of acute virus infections. However, falsely positive reactions due to rheumatoid factors (Fraser et al. 197I; Reimer et al. I975) , anti-nuclear antibodies belonging to the IgM immunoglobulin class, or even IgM coated bacteria (Schmitz et al. I977) have been reported. These diagnostic pitfalls can be easily avoided either by pre-absorption of rheumatoid factors with IgGcoated latex particles or by using appropriate control antigens.
A problem which has been given little consideration concerns non-specific reactions apparently arising from the adsorption of human IgM molecules to cytoplasmic structures of virus infected cells, while non-specific binding of human IgG, particularly in cytomegalovirus (CMV) infected cells, has been investigated by several authors: evidence for such an IgG binding came from the observation that the IgG of practically every human being produces brilliant immunofluorescent staining of the cytoplasmic inclusions of CMV infected cells. This staining is no longer demonstrable, however, if the anti-complement immunofluorescence (ACIF) technique of Goldwasser & Rozansky (I958) is applied (Schmitz & Haas, 1972) . It has also been shown that even Fc-fragments of human IgG can produce this non-specific staining (Keller et al. 1976; Westmoreland et al. I976) . We have recently studied the binding of human IgM antibodies without antiviral activity to the cytoplasm of CMV infected cells. This non-specific IgM binding strongly interfered with the specific detection of IgM antibodies to CMV in an enzyme immunoassay. It could be reduced, however, if isolated nuclei were used instead of complete cell extracts as antigen (Schmitz et al. I977) .
A similar background reaction can be observed if IgM antibodies to Epstein-Barr virus (EBV) are tested for by immunofluorescence (Schmitz & Scherer, I972) . For this assay we used cell smears of 'aged' P3HRI cells which had been cultivated at 32 °C for about 2 weeks without changing the nutrition medium. The smears were either fixed in acetone or used unfixed but dried since 'aged' cells are obviously permeable for antibodies without any fixation. Immediately after drying and/or fixation, the smears were rinsed in phosphate buffered saline (PBS) and then serum dilutions (from I : 32 onwards) were incubated for 2 h at 37 °C. After 3o min washing, FITC-labelled anti-human IgM globulin (diluted 1:5o; Hyland Laboratories, Costa Mesa, Calif., U.S.A.) was added for 3o min at room 
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temperature and the tests were read after a final 30 min wash. Especially with serum at low dilutions or with concentrated, purified human IgM fractions an intense fluorescent staining of the cytoplasmic areas of most lymphoblastoid cells can be seen and a reliable reading of the smears is difficult. On the other hand, this cytoplasmic staining no longer interferes when the ACIF technique is used to detect IgM antibodies (Fig. I a) . For this technique we employed human serum without EBV antibodies (diluted I : 8o) as source of complement and tetramethylrhodamine-labelled anti-human C3-globulin (diluted 1:2o) for the final staining step. Thus specific fluorescence can be differentiated from background staining if purified IgM antibody fractions are tested both by the indirect and by the ACIF method, the latter detecting only antibodies which have reacted with an antigen.
Since non-specifically binding IgM antibodies in the cytoplasm of the lymphoblastoid cells do not fix complement, they probably react with their F~-region. We therefore looked for a chemical substance which might inactivate possible Fo-receptors without affecting the antigenicity of the virus structural antigens. After testing several fixatives or enzymes it became apparent that the application of 3.7% formaldehyde (37% solution diluted 1:10 in PBS; Ross et al. I973; Knez et al. I976) fulfilled the above conditions. After a IO min incubation of the air-dried EBV containing lymphoblastoid cells, followed by a short washing, the antigenicity of the virus capsid antigens seemed to be unchanged, while, even with low dilutions, the non-specific background staining was no longer demonstrable. After an overnight wash at 4 °C the cell smears could be stored frozen at -20 °C in Io % glycerol-PBS without loss of antigenicity. As with any intracellular detection of IgM antibodies, drying of the fixed cell smears must be avoided (Schmitz & Scherer, i972) as this probably inhibits the penetration of the large IgM molecules through the cellular membranes. Due to reduced background activity after formaldehyde treatment, serum dilutions of less than I : I6 can be applied in the immunofluorescence detection of EBV IgM antibodies with a marked increase in the sensitivity of the method.
We further examined the non-specific binding of human myeloma IgM to different commercially obtainable antigens. Both complement-fixation reagents, the 'central European encephalitis' (CEE) virus antigen and the CMV antigen (Behringwerke, Marburg, Germany) are prepared by hypotonic rupture of virus-infected human fibroblasts. The binding of human IgM was detected by a solid-phase enzyme immunoassay (Schmitz et al. I977) . In brief, the antigens (diluted 1:4) were air-dried to glass plates and then fixed either in acetone or formalin (I : xo in PBS) for Io rain at 4 °C. After washing, the sera were incubated for 1.5 h on the antigen-coated glass plates and finally the human IgM molecules were detected by horseradish peroxidase-labelled anti-IgM globulin (diluted I:2OO; Dacopatts, Copenhagen).
As can be seen in Table I , the specific IgM antibody titre to the formalin as well as to the acetone treated CEE virus antigen are identical, while the non-specific binding of human myeloma IgM is clearly reduced after formalin as compared to acetone fixation. On the other hand an identical formalin treatment of the CMV antigen did not completely reduce the non-specific IgM binding. Here a nuclear antigen prepared from the nuclei of CMVinfected cells gives more satisfactory results. In principle, nuclei can be obtained from pre-swollen and homogenized CMV infected cells by low speed centrifugation on o'25 M-sucrose, as described in detail elsewhere (Schmitz et al. I977) . Such a nuclear antigen will no longer contain immunoglobulin receptors, which are only located in the cytoplasm of CMV infected cells (Schmitz & Haas, 1972, Keller et al. I976; Westmoreland et al. I976) .
The role of formalin as a fixative requires further comment. As can easily be seen from immunofluorescence testing, formalin in the low concentrations applied here does not by
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Serum containing specific IgM antibody Human myeloma IgM (5 mg/ml) Virus-specific IgM antibodies are usually detected by FITC-, iodine-or enzyme-labelled anti-human-IgM globulin, which does not differentiate between specifically or nonspecifically bound IgM antibodies. Thus non-specific reactions will probably occur with low serum dilutions in many IgM antibody assays, if cytoplasmic structures are present in the antigens used. Serum specimens containing high concentrations of human IgM without specific antibody activity (i.e. myeloma sera) should therefore be included as negative controls. The non-specific binding of IgM to cytoplasmic structures can be reduced either by employing nuclear antigens, by formalin treatment or eventually by purification of the virus antigens.
